Cargando…

P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY

Detalles Bibliográficos
Autores principales: Grace, R. F., Glenthøj, A., Barcellini, W., Verhovsek, M., Rothman, J. A., Morado Arias, M., Layton, D. M., Andres, O., Galactéros, F., van Beers, E. J., Onodera, K., Viprakasit, V., Chonat, S., Porter, J. B., Judge, M. P., Kosinski, P. A., Hawkins, P., Gheuens, S., Xu, R., McGee, B., Beynon, V., Al-Samkari, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431292/
http://dx.doi.org/10.1097/01.HS9.0000849036.11558.e5
_version_ 1784780014163591168
author Grace, R. F.
Glenthøj, A.
Barcellini, W.
Verhovsek, M.
Rothman, J. A.
Morado Arias, M.
Layton, D. M.
Andres, O.
Galactéros, F.
van Beers, E. J.
Onodera, K.
Viprakasit, V.
Chonat, S.
Porter, J. B.
Judge, M. P.
Kosinski, P. A.
Hawkins, P.
Gheuens, S.
Xu, R.
McGee, B.
Beynon, V.
Al-Samkari, H.
author_facet Grace, R. F.
Glenthøj, A.
Barcellini, W.
Verhovsek, M.
Rothman, J. A.
Morado Arias, M.
Layton, D. M.
Andres, O.
Galactéros, F.
van Beers, E. J.
Onodera, K.
Viprakasit, V.
Chonat, S.
Porter, J. B.
Judge, M. P.
Kosinski, P. A.
Hawkins, P.
Gheuens, S.
Xu, R.
McGee, B.
Beynon, V.
Al-Samkari, H.
author_sort Grace, R. F.
collection PubMed
description
format Online
Article
Text
id pubmed-9431292
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94312922022-08-31 P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY Grace, R. F. Glenthøj, A. Barcellini, W. Verhovsek, M. Rothman, J. A. Morado Arias, M. Layton, D. M. Andres, O. Galactéros, F. van Beers, E. J. Onodera, K. Viprakasit, V. Chonat, S. Porter, J. B. Judge, M. P. Kosinski, P. A. Hawkins, P. Gheuens, S. Xu, R. McGee, B. Beynon, V. Al-Samkari, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431292/ http://dx.doi.org/10.1097/01.HS9.0000849036.11558.e5 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Grace, R. F.
Glenthøj, A.
Barcellini, W.
Verhovsek, M.
Rothman, J. A.
Morado Arias, M.
Layton, D. M.
Andres, O.
Galactéros, F.
van Beers, E. J.
Onodera, K.
Viprakasit, V.
Chonat, S.
Porter, J. B.
Judge, M. P.
Kosinski, P. A.
Hawkins, P.
Gheuens, S.
Xu, R.
McGee, B.
Beynon, V.
Al-Samkari, H.
P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY
title P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY
title_full P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY
title_fullStr P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY
title_full_unstemmed P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY
title_short P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY
title_sort p1545: durability of hemoglobin response and reduction in transfusion burden is maintained over time in patients with pyruvate kinase deficiency treated with mitapivat in a long-term extension study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431292/
http://dx.doi.org/10.1097/01.HS9.0000849036.11558.e5
work_keys_str_mv AT gracerf p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT glenthøja p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT barcelliniw p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT verhovsekm p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT rothmanja p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT moradoariasm p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT laytondm p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT andreso p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT galacterosf p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT vanbeersej p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT onoderak p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT viprakasitv p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT chonats p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT porterjb p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT judgemp p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT kosinskipa p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT hawkinsp p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT gheuenss p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT xur p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT mcgeeb p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT beynonv p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy
AT alsamkarih p1545durabilityofhemoglobinresponseandreductionintransfusionburdenismaintainedovertimeinpatientswithpyruvatekinasedeficiencytreatedwithmitapivatinalongtermextensionstudy